Actively Recruiting
UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study
Led by University of Manchester · Updated on 2026-02-06
600
Participants Needed
2
Research Sites
129 weeks
Total Duration
On this page
Sponsors
U
University of Manchester
Lead Sponsor
U
University of Cambridge
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this observational study is to develop a large, deeply characterised cohort that will be a platform for collaborative clinical and translational research into cardiovascular (CV) disease (CVD) and Immune-mediated-inflammatory-diseases (IMID). The main aim is to evaluate whether existing blood cardiac biomarkers predict adverse cardiovascular outcomes. The study will capture standard of care CV and associated health data (clinical, biochemistry/pathology and investigations) in patients across the IMIDs. Optional biological and/or imaging sub-studies will provide additional data and/or samples for associated analyses.
CONDITIONS
Official Title
UK CARDIOvascular Immune-Mediated Inflammatory Diseases (CARDIO-IMID) Registry Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Written informed consent
- Diagnosis of an immune-mediated inflammatory disease (IMID) confirmed by a rheumatologist
- Categorization into one of the following IMID-CVD groups: i. Higher risk of cardiovascular disease without history of CVD, including coronary artery disease with high clinical risk or elevated biochemical markers ii. New onset IMID with cardiovascular disease such as major adverse cardiovascular events or myopericardial involvement iii. Established IMID with a history of past cardiovascular events or known myopericardial involvement
- Participants receiving a cardiovascular magnetic resonance (CMR) scan as part of standard care may join the extended CMR sub-study
- No additional inclusion criteria for the biological sub-study
You will not qualify if you...
- Age under 18 years
- Unable to provide informed consent
- For the CMR sub-study: contraindications to CMR including metal implants, claustrophobia, inability to lie flat, or severe kidney impairment preventing MRI contrast use
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Royal Infirmary of Edinburgh
Edinburgh, Scotland, United Kingdom, EH16 4SA
Actively Recruiting
2
Countess of Chester Hospital NHS Foundation Trust
Chester, United Kingdom, CH2 1UL
Actively Recruiting
Research Team
G
Georgia Reeves
CONTACT
J
James Lawrence
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here